FdaApplication
NDA 212020
Identifiers
- fda_app_no: NDA212020
Properties
| Property | Value |
|---|---|
| applicant_name | EXELA PHARMA SCIENCES LLC |
| application_type | NDA |
| approval_date | 2019-04-15 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| TRANEXAMIC ACID | TRANEXAMIC ACID | 1GM/100ML (10MG/ML) | SOLUTION;INTRAVENOUS |
1 product